Drug facts
MoleculeAmlodipine (Norvasc)
Generics already compete: 18 makers on the market. 57 A-rated products from 18 makers substitute at the counter.
Norvasc was first approved by the FDA on 07/31/1992 under NDA 019787; the application holder is Viatris Specialty LLC.
The latest NADAC for AMLODIPINE BESYLATE 2.5 MG TAB is $0.01 per unit (as of 10/28/2026).
Holder Viatris Specialty LLCApplication NDA 019787Approved 07/31/1992
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Norvasc patent listed in the Orange Book Orange Book
- Later patents, other products
- Norliqva 02/24/2041 Orange Book
02Competition
- Generics
- 18 generic makers Orange Book
- First generic approved
- 10/03/2005 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Amlodipine profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
- NADAC
- $0.01 per unitAMLODIPINE BESYLATE 2.5 MG TAB, mid-priced of 3 strengths, as of 10/28/2026 CMS NADAC
- Latest recall
- 06/27/2023Class III, Amlodipine Besylate, Lupin Pharmaceuticals Inc. FDA enforcement
04Product
- Application holder
- Viatris Specialty LLC Orange Book
- Application
- NDA 019787 Orange Book
- First approved
- 07/31/1992 Orange Book
- Dosage forms
- for solution; solution; tablet
- Routes
- oral
- Other brand names
- NorliqvaSdamlo
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.